Research published this week shows that gold-coated nanoparticles can be used to detect tiny amounts of cancer-related molecules in blood.
The 9th International Nanomedicine Conference was held last week in Coogee, Sydney. Some of our researchers were there, showcasing their research and networking with colleagues from near and far.
Our researchers have used a tiny drug delivery vehicle to kill neuroblastoma cells without harming normal tissues.
Ground-breaking virtual reality (VR) technology is allowing multiple scientists to see inside a human cell at the same time.
Planning on a PhD in biomedical research? We have four prestigious scholarships on offer for the best and brightest.
This article, originally published in The Conversation, tells how nanomedicine packages and delivers cancer drugs where they’re needed.
Cell skeletons have been anti-cancer drug targets since the 1950s. Research suggests new ways to target them, says Dr Amelia Parker in Australasian Science this month.
Many anti-cancer drugs are highly toxic to patients. About 70% of childhood cancer survivors experience some side-effects from their treatment.
After the recent Oznanomed conference in Sydney, Prof Maria Kavallaris shares her big vision for the ‘little things’ in science and how they are heading toward better cancer treatments.